Form 4 for OPRX OptimizeRx Corp
Accepted 2021-07-28 00:00:00 ET · period of report 2021-07-27 · accession 0001213900-21-039109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-28 | 2021-07-27 | OPRX | BAKER DOUGLAS P | CFO | S - Sale | $52.58 | -3,000 | 76.8K | -4% | -$157.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-07-27 | S | D | 3,000 | $52.58 | 76,796 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |